SEARCH RESULTS FOR: "Tag: CLVS"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(2)
2019(4)
2018(4)
2017(5)
2016(7)
2015(2)
CATEGORIES
Analyst Update(3)
Analyst Upgrades(1)
Buzz Stocks(6)
By the Numbers(1)
Earnings Preview(1)
Ezines(1)
Intraday Option Activity(2)
Market Recap(1)
Midday Market Check(2)
Opening View(3)
Quantitative Analysis(1)
Stock Market News(3)
Stocks On the Move(3)
Technical Analysis(1)
Unusual Trading Activity(1)

2/20/2020 12:00 PM
Stocks are suddenly selling off sharply at midday, with the Dow Jones Industrial Average (DJI) down almost 300 points at last check. The losses are just as deep for the S&P 500 Index (SPX) and Nasd...
1/15/2020 9:12 AM
The shares of health care name Clovis Oncology Inc (NASDAQ:CLVS) are surging in electronic trading, following news the U.S. Food and Drug Administration (FDA) granted priority review status to its Ru...
5/29/2019 12:56 PM
This morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes...
3/4/2019 9:30 AM
The shares of Clovis Oncology Inc (NASDAQ:CLVS) are up 1.3% in electronic trading, on news the pharmaceutical firm's ovarian cancer treatment, rucaparib, is now available in Germany for women with re...
1/8/2019 12:12 PM
Yesterday, Clovis Oncology Inc (NASDAQ:CLVS) surged more than 18%, after better-than-expected sales numbers for its cancer drug Rubraca, as well as a bull note from Leerink. However, the good times f...
 
Special Offers from Schaeffer's Trading Partners